The November/December issue of The Pathologist examines how genomic medicine is revolutionizing rare disease. Learn how genomics is progressing at rocket speed; why rapid, reliable, and accessible sequencing is life-changing for patients; and just how AI and awareness fit into this quickly evolving picture.


Also in this issue…

The University of Texas Medical Branch is working to solve dwindling access for benign hematology patients

The importance of the phlebotomist’s poke plan

Why pathologists need to talk about tech

How overcoming lung cancer treatment resistance requires predictive biomarkers

And so much more: the architecture of ADHD and autism; existing AI in the lab; preparing for another pandemic; and Sitting Down With… Julie Feldstein, Chief Pathologist at HistoWiz, on the jump from academia to industry
Click here to read the issue!
This email was sent to {~email~} by info@newsletter.thepathologist.com. To ensure delivery of emails to your inbox, please add info@newsletter.thepathologist.com to your address book or safe sender list. To view online, please click here.

Create or manage your account here
Unsubscribe here

The Pathologist is a brand of Texere Publishing Limited (trading as Conexiant)

Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.